KIT and breast carcinoma: Accordingly, analysis of a cohort of breast cancer patients showed that the expression of c-Kit was significantly associated with TNBC subtypes, but the presence of positive lymph nodes and shorter disease-free survival periods were exclusively associated with the expression of Ki67 [34].